Drugs / Spirulina platensis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04988347 | Nov 2010 → Feb 2012 | dyspepsia, gastrin secretion abnormality, gastroesophageal reflux disease | Universidade de Passo Fundo | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spirulina platensis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04988347 ↗ |
| Route | Oral | “Active treatment with Spirulina platensis in capsules containing 530 mg, 1 capsule orally each 8 hours, for 60 days” NCT04988347 ↗ |